Last updated: 2026-10-14 19:29:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
PERRIGO COMPANY PLC (PRGO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $16.07, with a market capitalisation of $2.14B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.23 to $22.02. This page covers its latest market performance, valuation, price trends and company information.
$2.14B | |
$15.29 | |
$215.73 | |
$9.23 | |
$15.37 | |
3.79M | |
2.79M | |
-- | |
$22.02 | |
$9.23 | |
7.50% | |
-- |
PERRIGO COMPANY PLC (PRGO) is currently trading at $16.07 as of 2026-10-14 19:12:38, up 4.58% ($0.70) from the previous close of $15.37
During today's regular trading session, PRGO has traded between $9.23 and $215.73, with a trading volume of 3.79M shares. The current price is near the lower end of today's range.
Over the past seven days, PERRIGO COMPANY PLC (PRGO) moved from $14.44 to $16.07, representing a gain of 11.32% ($1.63).
The stock traded between $13.91 and $16.14 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 2.39 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 53.5%
PRGO is currently trading at $16.07, placing it 53.5% of the way from its 52-week low of $9.23 to its 52-week high of $22.02. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 8100 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of PERRIGO COMPANY PLC (PRGO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.